FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040751014> ?p ?o ?g. }

• W2040751014 endingPage "190" @default.
• W2040751014 startingPage "183" @default.
• W2040751014 abstract "The chemical compound [4-(4-bromo-2-cyano-phenylcarbamoyl)-benzyl]-phosphonic acid diethyl ester (NO-1886) is a lipoprotein lipase activator having beneficial effects on both diabetes control and the cardiovascular system. Preventing accumulation of lipids in the cell wall, in addition to improving insulin actions on vasculature, may indirectly contribute to the reducing effect of NO-1886 on vascular resistance. However, the direct effect of NO-1886 on vascular resistance, i.e., whether NO-1886 directly modulates the function of vascular endothelium and/or smooth muscle cells has not been investigated. In this study we therefore investigated the direct effect of NO-1886 on vascular contractility using rat aortic rings and cultured smooth muscle cell-line A10. The results show that administration of NO-1886 attenuated aortic contraction induced by phenylephrine and/or a high K + environment, in both the presence and absence of aortic endothelium. 1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine hydrochloride (ML-9), a myosin light chain kinase (MLCK) inhibitor, blocked this inhibitory effect of NO-1886, whereas inhibitors of other signaling molecules such as calmodulin, protein kinase C and Rho-kinase had no effect. The vasorelaxant effect of NO-1886 was blocked in the absence of extracellular Ca 2+ , or in the presence of the Ca 2+ channel inhibitor, verapamil. NO-1886 attenuated smooth muscle contraction induced by the cumulative addition of CaCl 2 . In A10 cells, NO-1886 inhibited the membrane depolarization-induced initial peak of [Ca 2+ ] i in the presence of extracellular Ca 2+ . This inhibition did not occur in the absence of extracellular Ca 2+ . Taken together these results demonstrate that NO-1886 attenuates smooth muscle contraction and causes vasorelaxation by an extracellular Ca 2+ - and MLCK-dependent mechanism." @default.
• W2040751014 created "2016-06-24" @default.
• W2040751014 creator A5008767253 @default.
• W2040751014 creator A5017425633 @default.
• W2040751014 creator A5020382541 @default.
• W2040751014 creator A5022613202 @default.
• W2040751014 creator A5038923350 @default.
• W2040751014 creator A5063877391 @default.
• W2040751014 creator A5085075864 @default.
• W2040751014 date "2007-01-01" @default.
• W2040751014 modified "2023-09-24" @default.
• W2040751014 title "NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta" @default.
• W2040751014 cites W1570313169 @default.
• W2040751014 cites W1753089048 @default.
• W2040751014 cites W1782741946 @default.
• W2040751014 cites W186790523 @default.
• W2040751014 cites W1966790513 @default.
• W2040751014 cites W1970784325 @default.
• W2040751014 cites W1972388850 @default.
• W2040751014 cites W1976741834 @default.
• W2040751014 cites W1979703755 @default.
• W2040751014 cites W1987683730 @default.
• W2040751014 cites W2000277552 @default.
• W2040751014 cites W2007406273 @default.
• W2040751014 cites W2010382458 @default.
• W2040751014 cites W2011594777 @default.
• W2040751014 cites W2020747538 @default.
• W2040751014 cites W2025570653 @default.
• W2040751014 cites W2045981019 @default.
• W2040751014 cites W2046772268 @default.
• W2040751014 cites W2062220906 @default.
• W2040751014 cites W2069296756 @default.
• W2040751014 cites W2082266318 @default.
• W2040751014 cites W2088567842 @default.
• W2040751014 cites W2111828569 @default.
• W2040751014 cites W2113974411 @default.
• W2040751014 cites W2125984804 @default.
• W2040751014 cites W2138742704 @default.
• W2040751014 cites W2141826379 @default.
• W2040751014 cites W2148499749 @default.
• W2040751014 cites W2151540642 @default.
• W2040751014 cites W2155253877 @default.
• W2040751014 cites W2162583700 @default.
• W2040751014 cites W2170401329 @default.
• W2040751014 cites W2406786892 @default.
• W2040751014 doi "https://doi.org/10.1016/j.ejphar.2006.09.059" @default.
• W2040751014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17109854" @default.
• W2040751014 hasPublicationYear "2007" @default.
• W2040751014 type Work @default.
• W2040751014 sameAs 2040751014 @default.
• W2040751014 citedByCount "5" @default.
• W2040751014 crossrefType "journal-article" @default.
• W2040751014 hasAuthorship W2040751014A5008767253 @default.
• W2040751014 hasAuthorship W2040751014A5017425633 @default.
• W2040751014 hasAuthorship W2040751014A5020382541 @default.
• W2040751014 hasAuthorship W2040751014A5022613202 @default.
• W2040751014 hasAuthorship W2040751014A5038923350 @default.
• W2040751014 hasAuthorship W2040751014A5063877391 @default.
• W2040751014 hasAuthorship W2040751014A5085075864 @default.
• W2040751014 hasConcept C126322002 @default.
• W2040751014 hasConcept C134018914 @default.
• W2040751014 hasConcept C163415756 @default.
• W2040751014 hasConcept C170493617 @default.
• W2040751014 hasConcept C181199279 @default.
• W2040751014 hasConcept C185592680 @default.
• W2040751014 hasConcept C2777022698 @default.
• W2040751014 hasConcept C2777952589 @default.
• W2040751014 hasConcept C2779395532 @default.
• W2040751014 hasConcept C28406088 @default.
• W2040751014 hasConcept C29688787 @default.
• W2040751014 hasConcept C2992686903 @default.
• W2040751014 hasConcept C519063684 @default.
• W2040751014 hasConcept C55493867 @default.
• W2040751014 hasConcept C6997183 @default.
• W2040751014 hasConcept C71924100 @default.
• W2040751014 hasConcept C8035138 @default.
• W2040751014 hasConcept C84393581 @default.
• W2040751014 hasConcept C86803240 @default.
• W2040751014 hasConcept C88045685 @default.
• W2040751014 hasConceptScore W2040751014C126322002 @default.
• W2040751014 hasConceptScore W2040751014C134018914 @default.
• W2040751014 hasConceptScore W2040751014C163415756 @default.
• W2040751014 hasConceptScore W2040751014C170493617 @default.
• W2040751014 hasConceptScore W2040751014C181199279 @default.
• W2040751014 hasConceptScore W2040751014C185592680 @default.
• W2040751014 hasConceptScore W2040751014C2777022698 @default.
• W2040751014 hasConceptScore W2040751014C2777952589 @default.
• W2040751014 hasConceptScore W2040751014C2779395532 @default.
• W2040751014 hasConceptScore W2040751014C28406088 @default.
• W2040751014 hasConceptScore W2040751014C29688787 @default.
• W2040751014 hasConceptScore W2040751014C2992686903 @default.
• W2040751014 hasConceptScore W2040751014C519063684 @default.
• W2040751014 hasConceptScore W2040751014C55493867 @default.
• W2040751014 hasConceptScore W2040751014C6997183 @default.
• W2040751014 hasConceptScore W2040751014C71924100 @default.
• W2040751014 hasConceptScore W2040751014C8035138 @default.
• W2040751014 hasConceptScore W2040751014C84393581 @default.
• W2040751014 hasConceptScore W2040751014C86803240 @default.

• next